BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8735717)

  • 1. Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme.
    Dahlstrom JE; Jain S; Sutton T; Sutton S
    Histopathology; 1996 May; 28(5):421-7. PubMed ID: 8735717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions.
    Dahlstrom JE; Sutton S; Jain S
    Histopathology; 1996 Jun; 28(6):537-41. PubMed ID: 8803597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of stereotactic breast biopsy in mammographically suspicious lesions].
    Jäger HJ; Schatz TH; Mehring UM; Kubasch M; Hennigs S; Gissler HM; Spörl HD; Mathias KD
    Rofo; 2000 Apr; 172(4):346-53. PubMed ID: 10961219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic 14 gauge core-biopsy of the breast: results from 101 patients.
    Frayne J; Sterrett GF; Harvey J; Goodwin P; Townsend J; Ingram D; Parsons RW
    Aust N Z J Surg; 1996 Sep; 66(9):585-91. PubMed ID: 8859155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological correlation of mammographically detected microcalcifications in stereotactic core biopsies.
    Dahlstrom JE; Jain S
    Pathology; 2001 Nov; 33(4):444-8. PubMed ID: 11827410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.
    Kirshenbaum KJ; Voruganti T; Overbeeke C; Kirshenbaum MD; Patel P; Kaplan G; Maker V; August C; Cavallino RP
    AJR Am J Roentgenol; 2003 Aug; 181(2):527-31. PubMed ID: 12876040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic 14G core biopsy of non-palpable breast cancer: what is the relationship between the number of core samples taken and the sensitivity for detection of malignancy?
    Rich PM; Michell MJ; Humphreys S; Howes GP; Nunnerley HB
    Clin Radiol; 1999 Jun; 54(6):384-9. PubMed ID: 10406340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of a vacuum-assisted biopsy device (Mammotome) in the early detection of breast cancer in the United Arab Emirates.
    Faour I; Al-Salam S; El-Terifi H; El Taji H
    Ann N Y Acad Sci; 2008 Sep; 1138():108-13. PubMed ID: 18837890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions.
    Burak WE; Owens KE; Tighe MB; Kemp L; Dinges SA; Hitchcock CL; Olsen J
    Arch Surg; 2000 Jun; 135(6):700-3. PubMed ID: 10843367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
    Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
    Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
    Mahoney MC; Robinson-Smith TM; Shaughnessy EA
    AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
    Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
    Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities.
    White RR; Halperin TJ; Olson JA; Soo MS; Bentley RC; Seigler HF
    Ann Surg; 2001 Jun; 233(6):769-77. PubMed ID: 11371735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary?
    Cawson JN; Malara F; Kavanagh A; Hill P; Balasubramanium G; Henderson M
    Cancer; 2003 Jan; 97(2):345-51. PubMed ID: 12518358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic breast biopsy: an audit of 18 months at BreastScreen Auckland.
    Greenberg D; Johnston J; Hart R; Weston M; Benson-Cooper D
    Australas Radiol; 2003 Sep; 47(3):261-7. PubMed ID: 12890246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?
    Jackman RJ; Birdwell RL; Ikeda DM
    Radiology; 2002 Aug; 224(2):548-54. PubMed ID: 12147855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic core biopsy of calcifications highly suggestive of malignancy.
    Liberman L; LaTrenta LR; Van Zee KJ; Morris EA; Abramson AF; Dershaw DD
    Radiology; 1997 Jun; 203(3):673-7. PubMed ID: 9169687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
    Fuhrman G; Cederbom G; Champagne J; Farr G; McKinnon W; Bolton J; Ordoyne WK
    J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspicious mammographic parenchymal abnormalities that are occult at ultrasonography.
    Gunawardena D; Tresham J; Hardie M; Phillips M; Wylie E
    J Med Imaging Radiat Oncol; 2014 Dec; 58(6):668-73. PubMed ID: 25088444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic vacuum-assisted core biopsy results for non-palpable breast lesions.
    Agacayak F; Ozturk A; Bozdogan A; Selamoglu D; Alco G; Ordu C; Pilanci KN; Killi R; Ozmen V
    Asian Pac J Cancer Prev; 2014; 15(13):5171-4. PubMed ID: 25040970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.